Welcome


The Ludwig Boltzmann Institute Applied Diagnostics (lbi:ad) is a translational research institution of the Ludwig Boltzmann Gesellschaft which is combining a team of transdisciplinary scientists, academic and industrial partners from several countries. It follows a new dual biomarker concept for tumor diagnosis. The focus of the institute lies on the development of non-invasive diagnostic methods combining molecular epigenetic and genetic signatures with molecular imaging biomarkers for PET and SPECT analysis. The combination of these two methods will allow for improved functional, spatial and temporal assessment of tumor load and molecular tumor characterization.


Epigenetics conference in Arabian Gulf University


Gerda Egger, Deputy and Head of Molecular Pathology, attended the first conference of the Arab Genetic Research Association. It was organised by Princess Al Jawhara
2nd DONAU SYMPOSIUM – including the CBmed Biomarker Conference


The 2nd “Danube Symposium” meeting, together with the 3rd CBmed Biomarker Conference, intended to provide a forum to open-minded experts both from academia
Frontiers in Urology
What is happening in Urology today?

Shahrokh F. Shariat, Head of the Department of Urology, initiated the meeting "Frontiers in Urology" in December 2017 and invited international pioneers and experts

Share This: